Isothermal Nucleic Acid Amplification Technology Market is Led by Hospitals

The isothermal nucleic acid amplification technology market was sized at USD 4,425.5 million in 2023, which will power at a rate of 9.4% by the end of this decade, to touch USD 8,159.4 million by 2030. This has a lot to do with the considerable rise in its use as a molecular testing method as a result of the increasing occurrence of communicable diseases.

TB, influenza, and hepatitis are amongst the main causes of death traceable to communicable ailments, particularly in developing nations.

Infectious diseases are a key reason for mortality and morbidity at a global level. This is why the snowballing incidence of communicable diseases is a key factor for the industry growth.

North America isothermal nucleic acid amplification technology market was the leader of the pack with around 45%, in 2023, and there will be a considerable growth in the years to come as well. This will be because of the recognized research infra and surge in the requirement for nucleic-acid-amplification-based diagnostics to for averting pandemics in the region.

The German market has a considerable share in Europe because of the rising elderly populace and considerable emphasis on the healthcare infra. As per the World Bank, the nation’s population, which was more than 65 years was around 19 million in 2021. These large elderly population will bring about a high prevalence of age-related ailments and communicable diseases. which would reinforce the market prospects for effective INAAT devices and reagents.

It is because of the changing lifestyles in developing countries of the world, the demand for isothermal nucleic acid amplification technology is on the rise. This trend will continue in the years to come as well.

Read More

Veterinary Equipment and Disposables Market was Led by Companion Animals

The size of the veterinary equipment and disposables market was USD 2,515.9 million in 2023, and it will propel at a rate of 9.2% by the end of this decade, to touch USD 4,620.4 million by 2030.

To learn more about this report: https://bit.ly/3O0u3X7

This has a lot to do with the increasing prevalence of zoonotic ailments, growing acceptance of companion animals, and mounting requirement for improved veterinary critical care. Cutting-edge technologies, for example wearables, can come good in tracking the pet’s health from infancy, through childhood and maturity, to old age.

Veterinarians employ wearable technologies, such as GPS systems, radiofrequency identification systems, and other sensors tracking the food intake, activity levels, and vitals, for pet monitoring.

Consumables led thew industry with a share of 60%, because of the increasing animal care spending and the snowballing count of sterilization procedures, needing high volumes of consumables.

Furthermore, they are employed for more than a few applications, such as wound management and airway management.

The rescue & resuscitation category in the equipment sub-segment will observe a significant growth in the future. This is because of the increasing frequency of cardiopulmonary arrest in dogs and cats, which requires fast patient valuation and an instant CPR administration.

Companion animals led the veterinary equipment and disposables market, because of the growth in their populace and surge in the emphasis on their care. As per the American Veterinary Medical Association, the count of both cats and dogs in households has gone up considerably.

Additionally, animal shelters are a vital source for new pet attainments, accounting for 38% of dogs and 40% of cats adopted in 2021.

Also, as per the NAPHIA, the demand for pet insurance in recent times has resulted from the increase in the adoption of numerous companion animals.

Veterinary clinics make the most use of veterinary equipment and disposables, because of the availability of numerous treatment options available. Animal welfare organizations have delivered guidelines to guarantee the standards to be employed in such places, which has increased the footfall here.

Also, across developed countries, the progress in this category is also because of the presence of more than a few vet clinics, performing an increasing count of surgeries.

APAC will have a significant growth in the future because of the increasing pet adoption rate, growing cattle population, fast urbanization, growing consciousness of animal health, and rising per capita animal health expenditure. 

Japan and China will showcase a considerable growth, because of the growing count of veterinary clinics and hospitals. Furthermore, the increasing research and development investments by the major players for the expansion of value-added products will power the regional industry.

The growing prevalence of zoonotic diseases has a lot to do with the mounting demand for veterinary equipment and disposables all over the world. The demand will continue to rise in the years to come as well.

Read More

North America was the Leader of the Multiplex Assays Market

The multiplex assays market produced USD 3,918 million revenue in 2023, and it will power at a rate of 9% by the end of this decade, touching USD 7,103.5 million by 2030.

To learn more about this report: https://bit.ly/4aNVHAn

The main factor powering the industry is the growing incidence of chronic ailments and infectious diseases. Also, the growing requirement for effective analytical platforms in research and medical diagnostics, to decrease the costs for researchers, healthcare providers, and patients, is a robust contributor.

On the basis of product, the consumables category led the industry with a share, of 45%, in 2023. It was because of the increase in the count of diagnostic tests and surge in research actions by life sciences companies.

For example, in January 2023, Novo Nordisk, a pharma company, publicized a USD 6-million grant for Durham Technical Community College, for supporting the later’s life sciences program and set up a novel training center with area of 35,000 square feet.

The protein-based category led the multiplex assays market, with a 50%, share in 2023, due to the growing applications of these kinds of products in proteomics studies. Furthermore, protein-based assays are extensively used in research to recognize the protein concentration, electrophoresis, cell biology and other analytes.

The flow cytometry category led the industry in 2023, because of the numerous applications of this tech in the discovery and measurement of proteins and RNA and in the assessment of cell health.

For instance, Life Sciences Core Facilities, the Flow Cytometry Unit, Weizmann Institute of Science’s is making the use of imaging flow analyzers that combine the high-amount quantification of flow cytometry with microscopy and aid in the study of post-translational alterations and protein, protein interactions in different contexts.

North America led the industry with a share of 55%, in 2023, and it will power at a considerable rate, as a result of the increase in the research and development activities by biotech and pharma companies for the expansion of new drugs and diagnostic solutions. 

For example, in Jan 2023, PharmaEssentia Corporation publicized plans for a new PIRC in Greater Boston, Massachusetts. Likewise, in October 2022, Lineage Cell Therapeutics Inc. publicized the opening of a novel research and development facility in California and the development of its GMP-compliant capability in Israel. Lineage’s novel facility in California will extend its R&D competences in the U.S. and support the expansion of present and future allogeneic cell transplant programs.

It is because of the growing prevalence of chronic and infectious diseases all over the world, the demand for multiplex assays is on the rise. This trend will also continue in the years to come as well.

Read More

Fill-Finish Manufacturing Market is Led by the Asia-Pacific Region

The fill-finish manufacturing market made a revenue of USD 10.1 billion in 2023, and it will touch a value of USD 20.7 billion by 2030, powering at a rate of 10.9% by the end of this decade, powered by the increasing requirement for injectables, as well as biologics and modified medicines.

This procedure plays a significant role in the pharma and biotech sectors by being the last stage in the production process, wherein biologic and synthetic drugs are dispensed into their containers and packed for distribution.

On the basis of the product, consumables led the industry with a share of 65%, in 2023, and it will be like this in the future as well. Consumables put to use in in the fill−finish procedure comprise vials, cartridges, syringes, caps, seals, stoppers, and filters.

APAC was the leader of the pack, with a share of about 45%, in 2023, and this trend will continue in the years to come as well. The main region for this is that the region has a strong presence of pharma and biotech companies.

China, Japan, India, and South Korea are the hubs for pharma production and R&D activities. These have well-established pharma infra, a large and skilled workforce, and advantageous guidelines of the government supporting the development of related businesses. 

Furthermore, more than a few biotech and pharma companies from Europe and North-America outsource their final-stage production process to firms based in the region on contract.

It is because of the growing demand for injectables and continuous advancements in technology all over the world, the demand for fill-finish manufacturing is on the rise, This trend will continue in the years to come as well.

Read More

Allergy Diagnostics Market is Led by North America

The allergy diagnostics market is estimated to reach USD 6,103.3 million in 2023, which will touch USD 12,814.2 million, with an 11.2% compound annual growth rate, by 2030.

The growth of this industry is because of the rising levels of environmental pollution, increasing investment to enhance allergy diagnostics by private & public administrations, and the occurrence of allergic disorders.

Furthermore, the inactive lifestyles, characterized by smoking, consumption of alcohol, and poor food habits; coupled with the high demand for in-vitro blood testing will further boost the industry expansion.

The consumables category, based on offering, is leading the industry in 2023, with a 45% share. This can be because consumables are an important component in detecting allergies.

North America is leading the industry in 2023, with a 55% share. This can be because of the strong healthcare system, swift technological developments in the medical sector, and advantageous reimbursement rules.

Additionally, the surging occurrence of allergies, coupled with the presence of inspiring procedures by associations to increase consciousness and make treatment and diagnosis available are also major contributors.

APAC will progress at the highest rate, of 11.5%, in the years to come. This can be primarily attributed to the requirement for less-invasive diagnostic technologies, speedily growing medical infrastructure, surging medical tourism activities, and unfulfilled clinical requirements.

With the rising levels of environmental pollution, the allergy diagnostics industry will continue to progress in the years to come.

Read More

North America Is Dominating In-Situ Hybridization Industry

In 2023, the in-situ hybridization market amounted to USD 1,742.3 million and is set to grow at a compound annual growth rate of 12.8% between 2024 and 2030 reaching an estimated amount of USD 4,017.3 million by 2030.

This development of the market can be credited to the increasing acceptance of the in-situ hybridization (ISH) process for identifying numerous genetic illnesses and cancer, the rising pace of improvements in this method, and growing private and public funding for the research and development sector. Moreover, the rising demand for modified medicines is projected to fuel the industry growth.

There has been a distressing surge in cases of cancer worldwide in the past few years. This has caused a surge in the number of examined studies connected with this illness and those revolving around certain genomic irregularities, which are likely risk factors for numerous types of carcinomas.

In 2023, the FISH technology had a significant share, credited to the extensive variety of applications of this tech in diagnostics, like characterization with the aid of marker chromosomes, finding of numerical and structural chromosome flaws, finding of unusual and hereditary conditions, and drug abuse tracking.

In 2023, the North American region, generated the largest revenue share, of 55%, in the worldwide industry for in-situ hybridization solutions. The North American industry is projected to continue to uphold its dominating position during the projection period, mainly credited to the increasing count of autosomal diseases, cancer cases, genetic disorders, and also communicable conditions in the continent.

The U.S. is the key revenue generator in North America, mainly because of the strong government and private backing for the growth of new companion diagnostics methods.

Read More

Liquid Handling System Industry to Observe Fastest Growth In Asia-Pacific

In 2022, the liquid handling system market was USD 4,692 million, and it is expected to reach a value of USD 6,521 million growing at a rate of 4.20%, by 2030 as told in a report by P&S Intelligence.

To learn more about this report: https://bit.ly/3AMloAs

This growth is credited to the developing life science industry, increasing investment to develop efficient and innovative therapeutic agents by various companies, and the growing incidence of chronic diseases.

Furthermore, the demand for these products has increased considerably due to the outbreak of the COVID-19. These systems were used in all sorts of laboratory work during the testing of samples for the virus.

India and China, are offering opportunities to various life science companies and drug manufacturers. For example, Pfizer Inc. set up a research and development center at the Indian Institute of Technology Madras, to enhance pharmaceutical research in India.

APAC will grow the fastest, at a rate of over 5.1%, in the years to come, owing to the rising investments in biotechnology. 

China held the largest share in 2022, and it will advance significantly in the coming years. This is mainly credited to the number of research and development activities taking place in the life sciences industry.

Due to the developing life science industries, growing investment to develop effective and innovative therapeutic agents by companies, and rising incidence of chronic diseases, the demand for liquid handling system will grow considerably in the coming years.

Read More

Oligonucleotide Synthesis Market is Ultimately Generating $2.8 Billion in Revenue by 2023

Valued at $1.5 billion in 2017, the oligonucleotide synthesis market size is predicted to progress with a 10.8% CAGR during the forecast period 2018–2023, ultimately generating $2.8 billion in revenue by 2023. By definition, oligonucleotide synthesis is the artificial creation of oligonucleotides, which are short DNA or RNA fragments.

On the basis of offering, reagents and consumables, synthesized oligonucleotides, and equipment are the three market categories. Among these, synthesized oligonucleotides held the largest revenue share (76.3%) in 2017 and is also predicted to grow the fastest during the forecast period, at an 11.1% CAGR. The increase in contract manufacturing of DNAs and RNAs is expected to escalate the demand for synthesized oligonucleotides. Similarly, when segmented by application, the oligonucleotide synthesis market can be categorized into diagnostics, research, and therapeutics.

To Learn more About this report@ http://bit.ly/2UrgrJx

Among all, the research category led the market in 2017 and is expected to be the fastest growing (11.1% CAGR) category. This pays credence to the finding that of all the end users of synthetic oligonucleotides, including diagnostic laboratories, pharmaceutical and biotechnology companies, academic research institutes, and others, academic research institutes dominated the oligonucleotide synthesis market in 2017 with 40.4% revenue share. This further substantiates the fact that increasing research activities in the field is one of the key growth drivers of the market.

In addition, several new products have come in the oligonucleotide synthesis market, such as protecting amino groups, synthesizers with high throughput, and coupling reagents. Similarly, the development of the microarray technology is aiding the production of oligonucleotides for the diagnosis and treatment of diseases. Along with making the nucleotide assembly method efficient and correcting errors in synthesized enzymes, such developments are also helping in the steady progress of the market.

Now, the oligonucleotide R&D is itself being bolstered by growing government support in the form of funding and other initiatives. The U.S. government invested about $820 million in synthetic biology R&D between 2008 and 2014. Similarly, as per SynbiCITE an England-based organization, the U.K government invested over $400 million during 2009–2016 for establishing three training centers and six research institutes dedicated to synthetic biology. Thus, with favorable government attitude toward providing people with better levels of healthcare, the oligonucleotide synthesis market is predicted to continue on the path to prosperity.

Hence, it is clear that the increase in research and development in the synthetic biology field will further the market advance.

Read More